Cargando…
Targeted 1,3-dipolar cycloaddition with acrolein for cancer prodrug activation
Cytotoxic anticancer drugs used in chemotherapy are often antiproliferative agents that preferentially kill rapidly growing cancer cells. Their mechanism relies mainly on the enhanced proliferation rate of cancer cells and is not genuinely selective for cancer cells. Therefore, these drugs can also...
Autores principales: | Pradipta, Ambara R., Ahmadi, Peni, Terashima, Kazuki, Muguruma, Kyohei, Fujii, Motoko, Ichino, Tomoya, Maeda, Satoshi, Tanaka, Katsunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873552/ https://www.ncbi.nlm.nih.gov/pubmed/35340932 http://dx.doi.org/10.1039/d0sc06083f |
Ejemplares similares
-
Bioorthogonal prodrug activation driven by a strain-promoted 1,3-dipolar cycloaddition
por: Matikonda, Siddharth S., et al.
Publicado: (2015) -
Understanding the 1,3‐Dipolar Cycloadditions of Allenes
por: Yu, Song, et al.
Publicado: (2020) -
The Huisgen Reaction: Milestones of the 1,3‐Dipolar Cycloaddition
por: Breugst, Martin, et al.
Publicado: (2020) -
Therapeutic efficacy of (211)At-radiolabeled 2,6-diisopropylphenyl azide in mouse models of human lung cancer
por: Ode, Yudai, et al.
Publicado: (2023) -
Dynamic Catalytic Highly Enantioselective 1,3‐Dipolar Cycloadditions
por: Yildirim, Okan, et al.
Publicado: (2021)